Overall, Intuitive Surgical maintains a strong business model buoyed by solid financial performance and innovative product offerings. However, challenges in international markets and margin pressures may affect future growth. The company shows promising growth prospects through continued R&D investment and market expansion, while navigating competitive pressures.
Analysis Date: January 23, 2025 Last Updated: May 29, 2025
+935%
+26.3% per year
Past performance does not guarantee future results. The data presented is indicative and may not be updated in real-time.
CountryUS
ExchangeNASDAQ
IndustryMedical - Instruments & Supplies
SectorHealthcare
Market Cap$193.18B
CEODr. Gary S. Guthart Ph.D.
Intuitive Surgical, Inc. makes advanced robotic systems that help doctors perform surgeries with less cutting and quicker recovery for patients. Their main product, the da Vinci Surgical System, allows surgeons to do complex procedures through small openings in the body instead of large cuts. The company also provides tools and support to help hospitals use their technology effectively. Overall, Intuitive Surgical focuses on improving how surgeries are done to make them safer and easier for patients.
Streams of revenue
Instruments and Accessories:62%
Systems:22%
Services:16%
Geographic Distribution
Asia:0%
Other:0%
Europe:0%
United States:0%
Estimations for reference only
Core Products
👁️
Vision SystemsSurgical imaging
📚
Training ServicesSurgical training
🔧
Surgical InstrumentsTools for surgery
🫁
Ion Endoluminal SystemLung biopsy system
🤖
da Vinci Surgical SystemRobotic surgery system
Business Type
Business to Business
Competitive Advantages
Unlock Competitive Advantages Analysis
Discover all competitive advantages and strategic moats that protect ISRG's market position.
Trailing Twelve Months (TTM) values provide a view of the company's performance over the last year.
Graham Value Metrics
Benjamin Graham's value investing approach focuses on finding stocks with a significant margin of safety between their intrinsic value and market price.
📊
Unlock Graham value analysis
Access Benjamin Graham's value investing criteria, intrinsic value calculations, and margin of safety analysis
Trailing Twelve Months (TTM) values provide a view of the company's performance over the last year.
Income Statement Flow
Scroll horizontally to see more
About Profitability Metrics
Profitability metrics measure a company's ability to generate earnings relative to its revenue, operating costs, and other relevant metrics. Higher values generally indicate better performance.
📊
Unlock Profitability Metrics
Access detailed profitability metrics with visual gauges and benchmarks
ISRG Stock Analysis: Intuitive Surgical, Inc. Investment Guide
ISRG (Intuitive Surgical, Inc.) is a Healthcare company listed on NASDAQ Global Select. The stock has generated 26.3% annual returns with an overall investment score of None/100.
Overall, Intuitive Surgical maintains a strong business model buoyed by solid financial performance and innovative product offerings. However, challenges in international markets and margin pressures may affect future growth. The company shows promising growth prospects through continued R&D investment and market expansion, while navigating competitive pressures.
ISRG Key Financial Metrics
ISRG financial analysis includes comprehensive valuation ratios, profitability metrics, and financial health indicators. and profitability score of 5.0/100 with financial health rated 8.4/100.
About Intuitive Surgical, Inc.
Intuitive Surgical, Inc. makes advanced robotic systems that help doctors perform surgeries with less cutting and quicker recovery for patients. Their main product, the da Vinci Surgical System, allows surgeons to do complex procedures through small openings in the body instead of large cuts. The company also provides tools and support to help hospitals use their technology effectively. Overall, Intuitive Surgical focuses on improving how surgeries are done to make them safer and easier for patients.
ISRG Investment Recommendation
Based on our comprehensive analysis of ISRG, investors should consider the company's strong performance track record, earnings consistency (9/10 quarters beat expectations), and current valuation metrics when making investment decisions.
Healthcare Sector Analysis
ISRG operates in the Medical - Instruments & Supplies industry within the Healthcare sector. This analysis compares Intuitive Surgical, Inc. performance against industry and sector benchmarks to provide context for investment decisions.
Frequently Asked Questions about ISRG Stock
Is ISRG a good investment?
ISRG (Intuitive Surgical, Inc.) has generated 26.3% annual returns with an overall score of None/100. Overall, Intuitive Surgical maintains a strong business model buoyed by solid financial performance and innovative product offerings. However, challenges in international markets and margin pressures may affect future growth. The … Investors should consider their risk tolerance and investment goals when evaluating ISRG.
What is ISRG P/E ratio and valuation?
ISRG valuation metrics including P/E ratio, price-to-book ratio, and price-to-sales ratio are analyzed on this page with comparisons to Medical - Instruments & Supplies industry and Healthcare sector benchmarks.
Should I buy ISRG stock now?
The decision to buy ISRG stock should be based on comprehensive analysis of financial metrics, market conditions, and individual investment goals. Our analysis provides profitability score of 5.0/100, financial health score of 8.4/100, and detailed performance metrics to help inform your investment decision.
What are ISRG financial health indicators?
ISRG financial health analysis includes liquidity ratios, debt levels, cash flow metrics, and profitability indicators. The company has a financial health score of 8.4/100 based on comprehensive analysis of balance sheet strength and operational efficiency.
How does ISRG compare to competitors?
ISRG performance is benchmarked against Medical - Instruments & Supplies industry peers and Healthcare sector averages. Our analysis includes comparative valuation ratios, profitability metrics, and growth indicators to provide context for Intuitive Surgical, Inc.'s market position.
What are ISRG historical returns?
ISRG has generated 26.3% annual returns over the 10Y. Historical performance analysis includes price appreciation, dividend yields, and total shareholder returns compared to market benchmarks.
ISRG Key Investment Metrics Summary
Annual Return: 26.3%
Profitability Score: 5.0/100
Financial Health Score: 8.4/100
Growth Score: 6.374474268425626/100
Earnings Beat Rate: 9/10 quarters
Sector: Healthcare
Industry: Medical - Instruments & Supplies
Exchange: NASDAQ Global Select
Market Cap: 193180804230
ISRG Investment Thesis
Intuitive Surgical, Inc. (ISRG) represents an excellent investment opportunity in the Healthcare sector. With an overall score of None/100, the company demonstrates areas for financial improvement.
Investment Strengths
Strong Profitability Margins
Return on Equity
Operating Profit Margin
No Debt Levels
Strong Liquidity Ratios
Strong Financial Performance
Innovative Product Launches
Market Expansion and Acquisitions
Growth in Procedure Volume
Investment in R&D
Expansion into New Indications
Investment Risks
High Valuation Ratios
Challenges in International Markets
Margin Pressures
Competitive Landscape
Potential Tariffs Impact
We use cookies to analyze site traffic and optimize your site experience.
By accepting, you consent to our use of cookies. Read our Privacy Policy to Learn more.